Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio cholerae O1 is a gram-negative bacterium responsible for cholera outbreaks. Attenuated strains are modified to reduce virulence and are used in live oral vaccines to stimulate an immune response against cholera. Key virulence factors include cholera toxin (CT) and toxin-coregulated pilus (TCP). The bacterium's ability to colonize the small intestine and produce CT leads to severe watery diarrhea. Epidemic strains often acquire mobile genetic elements that enhance their pathogenicity.
Attenuated strains stimulate an immune response without causing severe disease. Non-attenuated strains cause disease through cholera toxin production, leading to fluid and electrolyte loss.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 (Attenuated) (V. cholerae O1).